Our major goal is to identify biologically relevant pathways that can explain the high frequency of mutations at methylated CpG (mCpG) sequences in the p53 gene and other genes. It is an almost universally accepted dogma that these mutations are caused by spontaneous deamination of 5-methylcytosine. However, it can be calculated that only a few 5-methylcytosines deaminate spontaneously in double-stranded DNA per day in each cell. Our hypothesis is that mCpG transitions are not caused simply by deamination of 5-methylcytosine in double-stranded DNA but by other processes including, for example, mCpG-specific base modification by endogenous or exogenous mutagens, or, alternatively, by secondary factors operating at mCpG sequences and promoting deamination. We will test if oxidative and/or nitrosative DNA damage can cause C to T transition mutations at mCpG sequences preferentially. We will test if deamination of 5-methylcytosine glycol in oxidized DNA plays a role in this process. Similarly, we will test if agents that produce exocyclic (etheno) DNA adducts can preferentially target 5-methylcytosine. The effects of nitric oxide on mCpG mutagenesis will be tested using in vitro and in vivo systems. To support the in vitro mutagenesis studies, we will use bacteriophage lambda transgenic mice on a genetic background with manipulated levels of reactive oxygen species in order to elucidate the mutational consequences of in vivo oxidative stress in chromosomal reporter genes with high levels of CpG methylation. We will also test if deamination of 5-methylcytosine is enhanced by secondary factors that operate at mCpG sequences. Mammalian cells contain at least five proteins that can bind specifically to methylated CpGs. We will test if binding of these proteins to CpG-methylated DNA enhances deamination of 5-methylcytosine, alters the chemical reactivity of mCpG sequences towards endogenous or exogenous mutagens and/or affects repair and mutagenesis at these sites. In addition, we will investigate the role of AID and APOBEC homologues in mCpG mutagenesis. These approaches should increase our understanding of the basic mechanisms leading to the most common type of single base substitution in mammalian cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA084469-06
Application #
6914419
Study Section
Special Emphasis Panel (ZRG1-ONC-B (02))
Program Officer
Okano, Paul
Project Start
1999-10-01
Project End
2009-04-30
Budget Start
2005-07-01
Budget End
2006-04-30
Support Year
6
Fiscal Year
2005
Total Cost
$309,600
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Hanley, M P; Hahn, M A; Li, A X et al. (2017) Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia. Oncogene 36:5035-5044
Zhang, Xiaoying; Guo, Cai; Wu, Xiwei et al. (2016) Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1. Cancer Res 76:2824-35
Jung, Marc; Pfeifer, Gerd P (2015) Aging and DNA methylation. BMC Biol 13:7
Hahn, Maria A; Li, Arthur X; Wu, Xiwei et al. (2015) Single base resolution analysis of 5-methylcytosine and 5-hydroxymethylcytosine by RRBS and TAB-RRBS. Methods Mol Biol 1238:273-87
Jung, Marc; Kadam, Swati; Xiong, Wenying et al. (2015) MIRA-seq for DNA methylation analysis of CpG islands. Epigenomics 7:695-706
Jin, Seung-Gi; Xiong, Wenying; Wu, Xiwei et al. (2015) The DNA methylation landscape of human melanoma. Genomics 106:322-30
Hahn, Maria A; Li, Arthur X; Wu, Xiwei et al. (2014) Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors. Cancer Res 74:3617-3629
Kalari, S; Jung, M; Kernstine, K H et al. (2013) The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene 32:3559-68
Rauch, Tibor A; Wang, Zunde; Wu, Xiwei et al. (2012) DNA methylation biomarkers for lung cancer. Tumour Biol 33:287-96
Jin, Seung-Gi; Wu, Xiwei; Li, Arthur X et al. (2011) Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39:5015-24

Showing the most recent 10 out of 54 publications